Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line

Peptides

Volumn 22, Issue 12, 2000, Pages 1885-1893

  Fabry, Marlies ^a,b   Cabrele, Chiara ^b   Höcker, Hartwig ^a   Beck Sickinger, Annette G ^b,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Biotin and fluorescence labeling; Glioblastoma cells; Insulin; Insulin like growth factor 1 (IGF 1); Neuropeptides; Vasointestinal peptide (VIP)

Indexed keywords

BIOTIN; FLUORESCENT DYE; INSULIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PEPTIDE; SOMATOMEDIN C; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; INSULIN RECEPTOR; LIGAND; NEUROPEPTIDE Y RECEPTOR; SOMATOMEDIN C RECEPTOR; SUBSTANCE P RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIAGNOSIS; BINDING AFFINITY; CANCER THERAPY; CONTROLLED STUDY; INTERMETHOD COMPARISON; LABELING INDEX; LIGAND BINDING; PEPTIDE SYNTHESIS; RECEPTOR BINDING;

BINDING SITES; BINDING, COMPETITIVE; BIOTIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCEIN; GLIOBLASTOMA; HUMANS; INHIBITORY CONCENTRATION 50; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KINETICS; LIGANDS; PEPTIDES; PROTEIN BINDING; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TUMOR CELLS, CULTURED;

EID: 0034860463     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00328-4     Document Type: Article

References (20)

1. The IGF-I receptor in cancer research
2. Growth factor receptors and their ligands
3. Synthesis and characterization of photoreactive insulin-like growth factor 1 derivatives for receptor analysis
4. Transferrin conjugates of doxorubicin: Synthesis, characterization, cellular uptake, and in vitro efficacy
5. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells
6. Inhibition of human neuroblastoma growth by a specific VIP antagonist
7. Fluorescent ligands for the study of receptors
8. Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29)
9. LIGAND. A versatile computerized approach for characterization of ligand-binding systems
10. Beta-adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell line
11. Functional insulin-like growth factor I receptors are expressed by neural-derived continuous cell lines
12. Recombinant toxins for cancer treatment
13. Human insulin-like growth factor I receptor internalization. Role of the juxtamembrane domain
14. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors
15. From micromolar to nanomolar affinity: A systematic approach to identify the binding site of CGRP at the hCGRP1 receptor
16. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
17. Hormone-drug conjugates
18. A fast and inexpensive method for N-terminal fluorescein-labeling of peptides